# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA701388 | F | Ability to inhibit growth of human myelogenous leukemic cell line KBM-3 was determined in an in vitro MTT assay. | Homo sapiens | 3 | ALA1125235 | cell-based format | Scientific Literature | |
2. | ALA701389 | F | Ability to inhibit growth of human myelogenous leukemic cell line KBM-3 variant namely KBM-3/DOX, was determined in an in vitro MTT assay. | Homo sapiens | 3 | ALA1125235 | cell-based format | Scientific Literature | |
3. | ALA707921 | F | Ability to inhibit growth of L1210 leukemic cell lines was determined in an in vitro MTT assay. | Mus musculus | 5 | ALA1125235 | cell-based format | Scientific Literature | |
4. | ALA711694 | F | Ability to inhibit growth of doxorubicin-sensitive (MES-SA) uterine sarcoma cell line was determined in an in vitro MTT assay. | Homo sapiens | 5 | ALA1125235 | cell-based format | Scientific Literature | |
5. | ALA713912 | F | Ability to inhibit growth of doxorubicin-resistant (MES-SA/DOX) uterine sarcoma cell line was determined in an in vitro MTT assay. | Homo sapiens | 5 | ALA1125235 | cell-based format | Scientific Literature | |
6. | ALA759313 | F | Ability to inhibit growth of P388 leukemic cell line was determined in an in vitro MTT assay. | Mus musculus | 5 | ALA1125235 | cell-based format | Scientific Literature | |
7. | ALA848842 | F | Resistance index measured as the IC50 for resistant cells (KBM-3/DOX) to that of IC50 for sensitive cells(KBM-3) | 3 | ALA1125235 | assay format | Scientific Literature | ||
8. | ALA848843 | F | Resistance index measured as the IC50 for resistant cells (MES-SA/DOX) to that of IC50 for sensitive cells(MES-SA) | 5 | ALA1125235 | assay format | Scientific Literature |